Evidence map›Paper›PMID 40303062›Full record

ReviewTransboundary and emerging diseases2024

Syndemic Challenges: Addressing the Resurgence of Mpox Amidst Concurrent Outbreaks in the DRC.

Olaniyi Abideen Adigun, Olalekan John Okesanya, Mohamed Mustaf Ahmed, Bonaventure Michael Ukoaka, Don Eliseo Lucero-Prisno, Emmanuella Ogechi Onyeaghala, Emmanuel Ayomide Oluwasusi, Olamide Esther Ogunwale, Ayodeji Amos Faniyi

Abstract readReview
In one paragraph

Review in Transboundary and emerging diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olaniyi Abideen AdigunDepartment of Medical Laboratory Science, Nigerian Defence Academy, Kaduna, Kaduna State, Nigeria.ORCID https://orcid.org/0000-0002-2375-6375
Olalekan John OkesanyaDepartment of Public Health and Maritime Transport, University of Thessaly, Volos, Greece.ORCID https://orcid.org/0000-0002-3809-4271
Mohamed Mustaf AhmedFaculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia.ORCID https://orcid.org/0009-0006-5991-4052
Bonaventure Michael UkoakaDepartment of Internal Medicine, Asokoro District Hospital, Abuja, Nigeria.ORCID https://orcid.org/0009-0000-9367-2612
Don Eliseo Lucero-PrisnoDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0002-2179-6365
Emmanuella Ogechi OnyeaghalaDepartment of Medical Laboratory Science, Achievers University Owo, Owo, Ondo State, Nigeria.ORCID https://orcid.org/0000-0002-3908-5123
Emmanuel Ayomide OluwasusiDepartment of Medical Laboratory Science, University College Hospital, Ibadan, Oyo State, Nigeria.ORCID https://orcid.org/0009-0006-9786-0139
Olamide Esther OgunwaleDepartment of Medical Laboratory Science, Ladoke Akintola University of Technology, Ogbomosho, Nigeria.ORCID https://orcid.org/0009-0000-2859-1314
Ayodeji Amos FaniyiDepartment of Medical Laboratory Science, Joseph Ayo Babalola University, Ikeji Arakeji, Nigeria.ORCID https://orcid.org/0009-0003-9718-3623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Democratic Republic of Congo (DRC) faces a syndemic of infectious diseases, including monkeypox (mpox), cholera, measles, anthrax, and plague, worsening public health challenges and socioeconomic disparities. This review synthesizes and discusses epidemiological data and consequences of simultaneous outbreaks in the DRC between January 2023 and March 2024. The findings highlight a 6.7% fatality rate and 3319 confirmed cases of mpox, with significant outbreaks in Kinshasa and 22 other provinces. Anthrax occasionally surfaced among cattle-raising villages, measles affected fewer than five children susceptible to the disease, and cholera outbreaks persisted in North Kivu, South Kivu, and Tanganyika. Plague incidences, mostly bubonic, have been reported in Ituri province. Vulnerable groups, including children, mothers, the elderly, and those with compromised immune systems, face increased risks due to poor healthcare access, hunger, and underlying medical conditions. Cultural beliefs, healthcare system issues, and socioeconomic instability impede effective response tactics. This strain on the fragile healthcare system highlights the need for increased surveillance, immunization efforts, and community involvement. To mitigate the effects of syndemic outbreaks, strengthening the DRC's health systems through international cooperation, integrated public health initiatives, and improved access to healthcare is crucial.

Indexed as

AnthraxCholeraDisease OutbreaksMeaslesMpox, MonkeypoxAnimalsDemocratic Republic of the CongoHumansanthraxcholeraDemocratic Republic of Congoepidemiologymeaslesmonkeypoxmpoxplaguesyndemic

Identifiers

PMID40303062
PMCPMC12020385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.